Generative AI in Antimicrobial and Small-Molecule Drug Discovery
OVERVIEWUpdate: Added biomolecular network design framework. GenAI-Net extends generative AI drug discovery approaches by automating the design of biomolecular networks implementing desired dynamical functions. This framework addresses the inverse problem of discovering chemical reaction networks from behavioral specifications, accelerating discovery and expanding the design space. Applications span synthetic biology, therapeutic engineering, and diagnostic development, complementing existing small-molecule and antimicrobial discovery pipelines. --- CONTRADICTIONS
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.